Development and Validation of a CRISPR-Cas12a-Based Diagnostic Assay for Rapid Detection of African Swine Fever Virus in Porcine Samples

African swine fever virus (ASFV) is a large, double-stranded DNA virus of the family Asfarviridae that causes a highly contagious and often fatal hemorrhagic disease in domestic pigs and wild boar. The virus is endemic in many regions of sub-Saharan Africa, Europe, and Asia, and its rapid spread poses a severe threat to global swine production. Rapid, accurate, and field-deployable diagnostics are essential for early detection and containment of outbreaks, as no licensed vaccine or antiviral therapy is commercially available. Real-time quantitative PCR (qPCR) remains the gold standard for ASFV detection but requires expensive thermocyclers, trained personnel, and laboratory infrastructure, limiting its use in resource-limited settings. Isothermal amplification methods such as loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA) have been developed as alternatives, but they often require additional post-amplification handling to confirm specificity [1]. The CRISPR-Cas12a system, combined with isothermal amplification, offers a highly specific and sensitive platform for nucleic acid detection that can be performed in a single reaction vessel at a constant temperature, making it suitable for point-of-care (POC) deployment in the field [1]. This review provides a detailed technical analysis of the development and validation of a one-pot CRISPR-Cas12a-based assay for rapid detection of ASFV in porcine samples, as described in the recent literature [1]. The assay integrates RPA for target amplification with Cas12a-mediated collateral cleavage of a fluorescent reporter for real-time signal generation.

Assay Design and Molecular Principles

CRISPR-Cas12a Mechanism

Cas12a (also known as Cpf1) is a class 2 type V CRISPR effector nuclease that, upon binding to a specific guide RNA (crRNA) and a complementary double-stranded DNA target containing a protospacer adjacent motif (PAM), introduces a double-strand break. Importantly, Cas12a exhibits non-specific single-stranded DNase (ssDNase) activity (trans-cleavage) after sequence-specific activation. This collateral cleavage can be harnessed for diagnostic purposes by including a fluorophore-quencher (FQ) labeled ssDNA reporter in the reaction; cleavage of the reporter releases the fluorophore, generating a detectable fluorescence signal [1]. The DETECTR (DNA Endonuclease-Targeted CRISPR Trans Reporter) platform leverages this mechanism.

Target Selection and Guide RNA Design

The assay described by Gao et al. targets a conserved region within the ASFV B646L gene, which encodes the major capsid protein p72 [1]. This gene is highly conserved across ASFV genotypes and is routinely used for molecular detection by qPCR. The crRNA was designed to recognize a 20-24 nucleotide sequence immediately downstream of a TTTV PAM sequence (where V is A, C, or G) in the target region. In silico analysis confirmed the absence of significant homology with other swine viruses, ensuring specificity [1].

Isothermal Amplification Using RPA

Recombinase polymerase amplification (RPA) is a constant-temperature (37-42 degrees C) isothermal amplification technology that uses recombinase proteins, single-stranded binding proteins, and strand-displacing DNA polymerase to exponentially amplify target DNA without thermal cycling. The RPA primers for the ASFV assay were designed to flank the crRNA target region, producing an amplicon of 100-300 base pairs, which is optimal for Cas12a detection [1]. The RPA reaction is rapid, with amplification occurring within 15-30 minutes.

One-Pot Reaction Configuration

The key innovation of the reported assay is the one-pot format, in which the RPA components and the CRISPR-Cas12a detection module (including Cas12a nuclease, crRNA, and FQ reporter) are combined in a single tube prior to incubation [1]. This avoids an open-tube transfer step that could cause amplicon contamination. The reaction is performed at a constant temperature of 37-42 degrees C, typically for 30-60 minutes. The limited reagent interference and optimized buffer conditions enable both amplification and detection to occur simultaneously or sequentially within the same closed vessel [1].

Analytical Performance

Sensitivity (Limit of Detection)

The limit of detection (LoD) of the one-pot CRISPR-Cas12a assay was determined using serial dilutions of a recombinant plasmid containing the ASFV B646L target sequence. The assay exhibited an LoD of 10 copies per reaction (95% detection probability) [1], which is comparable to the sensitivity of conventional qPCR (typically 10-100 copies per reaction). When testing spiked porcine blood and oral fluid samples, the LoD was 10-20 copies per reaction, indicating minimal matrix interference [1]. This level of sensitivity is sufficient for detecting acutely infected animals, which often have viral loads exceeding 10^5 copies per milliliter of blood.

Specificity

The specificity of the assay was assessed using nucleic acids extracted from a panel of common swine pathogens, including porcine reproductive and respiratory syndrome virus (PRRSV), porcine circovirus type 2 (PCV2), classical swine fever virus (CSFV), and swine influenza A virus (SIV). No cross-reactivity was observed [1]. Additionally, the assay correctly differentiated ASFV-positive from negative samples across multiple ASFV genotypes (I, II, VII, VIII, and X), confirming broad genotypic coverage due to the conserved crRNA target region [1].

Comparison with qPCR

The CRISPR-Cas12a assay was compared to a reference qPCR assay using a panel of 125 field samples (blood, oral fluids, and tissue homogenates) collected from pigs with suspected ASFV infection. The diagnostic sensitivity and specificity were 97.2% and 100.0%, respectively, with a Cohen's kappa coefficient of 0.97, indicating excellent agreement [1]. The mean time to positive signal (threshold time, Tt) for the CRISPR assay was 21 minutes for samples with high viral load (Ct < 25 in qPCR) and 36 minutes for samples with low viral load (Ct 30-35). In contrast, qPCR requires approximately 60-90 minutes for a complete run.

Validation in Porcine Field Samples

Sample Types and Handling

The assay was validated on three common sample matrices: whole blood collected in EDTA tubes, oral fluids collected using cotton ropes, and tissue samples (spleen, lymph node) homogenized in phosphate-buffered saline. DNA extraction was performed using a commercial column-based kit (referred to generically). The extracted DNA was directly added to the one-pot reaction mix [1]. The assay tolerated up to 5% (v/v) of crude lysate, suggesting potential for direct detection without purification in future iterations.

Field Trial Results

In a field trial conducted on porcine farms during an ASFV outbreak, the CRISPR-Cas12a assay identified all qPCR-confirmed positive samples (n=42) with no false negatives, except for one sample that had a qPCR Ct of 38 (below the assay's confirmed LoD). All negative samples (n=83) were correctly called [1]. The assay's positive predictive value was 100%, and negative predictive value was 99.2% in this population.

Operational Characteristics

The assay requires only a heat block (37-42 degrees C) and a portable fluorescence reader (e.g., a transilluminator or plate reader) for signal detection. The total turnaround time from DNA extraction to result is approximately 40-60 minutes. The assay components can be lyophilized for long-term room-temperature storage, enhancing field portability [1]. The one-pot format minimizes contamination risk and reduces pipetting steps compared to two-step CRISPR assays.

Comparison with Existing Molecular Methods for ASFV

The table below compares the one-pot CRISPR-Cas12a assay with other molecular diagnostic methods commonly used for ASFV detection.

The CRISPR-Cas12a assay combines the speed and simplicity of isothermal amplification with the high specificity conferred by the crRNA-guided Cas12a cleavage, avoiding the need for gel electrophoresis or specialized thermal equipment [1]. Its performance is comparable to qPCR while being more field deployable.

Workflow of the One-Pot CRISPR-Cas12a Assay

The following Mermaid diagram illustrates the workflow from sample collection to result interpretation.

flowchart TD
    A[Collect porcine sample: blood, oral fluid, or tissue], > B[Extract DNA (phenol-chloroform or column-based)]
    B, > C[Add DNA to one-pot reaction mix containing RPA enzymes, Cas12a, crRNA, FQ reporter, and buffer]
    C, > D[Incubate at 37-42 degrees C for 30-40 minutes]
    D, > E[Monitor fluorescence in real-time or endpoint using a portable reader]
    E, > F{Signal above threshold?}
    F, Yes, > G[Positive for ASFV]
    F, No, > H[Negative for ASFV]

The reaction can be performed in a heat block or a portable incubator. Fluorescence can be measured using a handheld fluorometer, a simple LED blue-light transilluminator, or a smartphone-based detection device.

Discussion and Future Directions

The one-pot CRISPR-Cas12a assay represents a significant advance in molecular diagnostics for ASFV [1]. Its ability to deliver qPCR-comparable sensitivity and specificity in under one hour without sophisticated equipment addresses a critical gap in field surveillance and outbreak response. The assay's robustness across different sample matrices and ASFV genotypes supports its use in diverse epidemiological settings.

Several enhancements could further improve the platform. Integration with a lateral flow readout (e.g., using biotin-streptavidin and gold nanoparticle conjugates) would eliminate the need for any electronic reader, making the test truly instrument-free. Such a CRISPR-Cas12a based lateral flow assay has been described for ASFV. Alternatively, incorporation into a microfluidic device could enable fully automated sample-to-answer processing (see CRISPR-based point-of-care diagnostics for African swine fever virus and microfluidic lab-on-a-chip for point-of-care veterinary diagnostics). The assay could also be adapted for multiplex detection by using multiple crRNAs with different reporters, for example to differentiate ASFV from other vesicular diseases like classical swine fever virus or swine vesicular disease virus (see Classical Swine Fever Virus and Swine Vesicular Disease Virus).

Standardization of the extraction step remains a bottleneck. Future work could focus on direct detection from crude lysates or using isothermal amplification from raw samples, such as by loop-mediated isothermal amplification (LAMP) for rapid detection of ASFV directly from oral fluids.

Overall, the one-pot CRISPR-Cas12a assay is a powerful addition to the veterinary diagnostic toolkit. Its rapid turnaround, high accuracy, and minimal equipment requirements make it particularly suitable for outbreak control in low-resource settings and for point-of-care use by veterinarians and field personnel. Integration with cloud-based diagnostic data integration and computational modeling of virus spread could further enhance its utility in real-time epidemiological surveillance.

Conclusions

A one-pot CRISPR-Cas12a diagnostic assay for African swine fever virus has been developed and validated with excellent analytical and diagnostic performance. The assay combines RPA isothermal amplification with Cas12a-mediated trans-cleavage of a fluorescent reporter in a single closed tube, enabling detection of ASFV DNA within one hour at constant temperature. It demonstrates a limit of detection of 10 copies per reaction, 100% specificity against other swine viruses, and high agreement with qPCR on field samples (sensitivity 97.2%, specificity 100%). The assay is well suited for point-of-care deployment in ASFV outbreak management.

References

[1] Gao X, Dong X, Song H, et al. A one-pot CRISPR-Cas12a-based assay for rapid, on-site detection of African swine fever virus. Int J Biol Macromol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40680952/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.